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Abstract Objective This was a retrospective observational study in patients submitted to
intramedullary nail fixation after established or impeding pathological humerus-shaft
tumoral fracture in the context of disseminated tumoral disease along 22 years of
experience at the same institution.
Methods Sample with 82 patients and 86 humeral fixations with unreamed rigid
interlocking static intramedullary nail by the antegrade or retrograde approaches.
Results The most prevalent primary tumors were breast carcinoma (30.49%), multi-
ple myeloma (24.39%), lung adenocarcinoma (8.54%), and renal cell carcinoma
(6.10%). The average surgical time was 90.16  42.98 minutes (40–135 minutes).
All of the patients reported improvement in arm pain and the mean Musculoskeletal
Tumor Society (MSTS) score rose from 26% in the preoperative period to 72.6% in the
evaluation performed in patients still alive 3 months after the surgery. The overall
survival was 69.50% 3 months after the surgery, 56.10% at 6 months, 26.70% at 1 year,
and 11.90% at 2 years. No death was related to the surgery or its complications. There
were only 4 surgery-related complications, 1 intraoperative and 3 late, corresponding
to a 4.65% complication risk.
Conclusion Closed unreamed static interlocking intramedullary nailing (both in the
antegrade or retrograde approaches) of the humerus is a fast, safe, effective, and low
morbidity procedure to treat pathological fractures of the humerus shaft, assuring a
stable arm fixation and consequently improving function and quality of life in these
patients during their short life expectation.
 Work developed at the Serviço de Ortopedia e Traumatologia,
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The frequency of bone tumor conditions, especially of bone
metastatic disease, increased markedly in recent years, and
longbones are frequent sites of this typeof lesion. Thehumerus
is the second bone most affected by metastatic disease in the
appendicular skeleton (ranging from 16 to 20% of the cases),
followed by the femur.1–3 Metastatic humeral lesions are
mostly lytic, and are associated with bone fragility and in-
creased risk of fracture; however, only 8 to 10% of these lesions
evolve to an established or impending fracture. Pathological
humeral fractures account for 16 to 39% of all pathological
fractures in long bones.1,4–7 As a general rule, the pathological
humeral shaft fracture occurs late in the evolution of tumoral
disease after minor or spontaneous trauma during activities,
and it is an important negativeprognostic andmorbidity factor,
causing pain, as well as loss of limb function and independent
living; moreover, it often requires supportive care, including
hygiene measures, which significantly reduces the quality of
life of these patients in their supposed little time left (approxi-
mately 1 year after the appearance of bone metastases in
disseminated tumor disease).1,2,4,5,8–12 The conservative treat-
ment option with immobilization of the pathological humeral
fractures had poor results, with insufficient pain reduction and
little function improvement, mainly due to the reduced con-
solidation potential of these lesions because of the biological
and mechanical effects of the tumor.3–6,8,10,11 As such, osteo-
synthesis is the current gold standard treatment for diaphyseal
humeral fractures inpatientswith disseminated tumor disease
who do not present with contraindications to the proce-
dure.1,3,10,11,13–17 This treatment is essentially palliative and
aims at the immediate effective stabilization of the fracture
(since one cannot expect or wait for consolidation), pain relief,
and recovery of limb mobility, seeking to restore functional
independence and quality of life as early as possible, preferably
without further surgical intervention. The reduced invasive-
ness andminimal tissue aggressionof the surgical technique, as
well as good results in immediate stabilization, pain relief and
rapidfunctional recovery, aswell as thereducedrateofsurgery-
related complications,made the closed intramedullary humer-
al nailing the best option in established or impending diaphy-
seal fractures.1,3–7,10,13–15 Although not an innovative
treatment, researches on this specific osteosynthesis method
in the context of pathological humeral fractures and its results
are limited to small samples. The present study aimed to
analyze a series of patients with pathological humeral diaphy-
seal fractures treatedwith closed unreamed static interlocking
intramedullary nailing and their clinical-functional and radio-
graphic results, focusing on postfixation survival time and
surgery-related complications.
Material and Methods
This was a retrospective observational study with 101 con-
secutive patients submitted to palliative humeral stabiliza-
tion with an unreamed static interlocking intramedullary
nail after the diagnosis of established or imminent patho-
logical fracture (the latter defined by aMirels18 score > 8) of
Resumo Objetivo Estudo retrospectivo observacional em pacientes submetidos à fixação com
haste intramedular de fratura patológica tumoral consumada ou iminente da diáfise do
úmero em contexto de doença tumoral disseminada ao longo de 22 anos na mesma
instituição.
Métodos Amostra com 82 pacientes e 86 fixações do úmero com haste intramedular
rígida bloqueada estática não fresada anterógrada ou retrógrada.
Resultados Os tumores primários mais prevalentes foram carcinoma da mama
(30,49%), mieloma múltiplo (24,39%), adenocarcinoma do pulmão (8,54%) e carci-
noma das células renais (6,10%). O tempo médio de intervenção cirúrgica para fixação
com haste foi 90,16  42,98 minutos (40-135). Todos os pacientes referiram melhoria
das queixas álgicas no nível do braço e velicou-semelhoria do score MSTSmédio de 26%
no pré-operatório para 72,6% na avaliação efetuada nos pacientes ainda vivos aos três
meses de pós-operatório. A taxa de sobrevivência aos três meses após a cirurgia foi de
69,50%, 56,10% aos seis meses, 26,70% em um ano e 11,90% em dois anos. Nenhuma
das mortes decorreu da cirurgia ou de complicações dela. Apenas se registaram quatro
complicações relacionadas com a cirurgia, uma intraoperatória e três tardias, corres-
ponderam a risco de complicações de 4,65%.
Conclusão O uso de haste intramedular não fresada estática bloqueada (anterógrado
ou retrógrado) no úmero é um método rápido, seguro, eficaz e com baixa morbilidade
no tratamento das fraturas patológicas da diáfise umeral, garante fixação estável do
braço e consequentemente melhora a funcionalidade e a qualidade de vida desses
pacientes durante a sua curta expectativa de vida.
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the humerus diaphysis in the context of tumor metastasis
over 22 years at the same institution. A total of 19 patients
were excluded from the sample because of data insufficiency,
and the final sample consisted of 82 patients. The evaluation
included demographics, primary neoplasm location and
type, regional diaphyseal distribution of the humeral tumor
lesion, surgical intervention time, nailing approach, nail
dimensions, time of hospitalization, complications, and post-
operative survival time.
A clinical and functional assessment of the upper limbwas
performed based on the Musculoskeletal Tumor Society
(MSTS) scoring system.19 In addition, a radiographic evalua-
tion of the humerus was also performed; consolidation was
defined by the disappearance of pathological fracture hypo-
lucency and the presence of a bone callus. All of the nailing
procedures were closed, performed with unreamed devices,
and the locking nail was static and associated with three or
four proximal and distal bicortical screws. All of the patients
were evaluated in an orthopedic visit at 6 weeks, 3 months
and 6 months after the surgery or until the date of death. In
addition, all of the patients received or continued to receive
antineoplastic treatment with radiotherapy and/or chemo-
therapy. Some patients, particularly those with hypervascu-
lar tumors, such as renal cell and thyroid carcinomas and
multiple myeloma, underwent an angioembolization of the
humeral tumor lesion prior to the nailing. The date of death
of the patients, if the death certificate was not available, was
considered as the date of the first missed visit or scheduled
treatment without rescheduling or a new attendance. Al-
though it was not possible to recover all data from all of the
patients, the total of cases without this information was
always < 20%. In these situations, missing data were
replaced by average values of the remaining ones. In calcu-
lating the mean time of the surgical intervention, 8 patients
(9.76%) were excluded, since their nailing procedure was
performed at the same time as other surgical interventions.
Data was statistically treated using IBM SPSS Statistics for
Windows, Version 23.0 (IBM Corp., Armonk, NY, USA). Values
are presented in absolute number (n) and percentages (%),
which are preferred as a central trend measure to the mean,
whereas standard deviation (SD) (minimum value–maxi-
mum value) is preferred as a measure of dispersion. Survival
curves were calculated using the Kaplan-Meier method. All
of the patients or their families signed the informed consent
form and the present study was approved by our institution.
Results
We present a sample of 82 patients submitted to 86 humeral
fixations with intramedullary nail in the context of an
established fracture (►Fig. 1) or of an impending fracture
(►Fig. 2) due to a tumoral lesion. The mean age of the
patients at the time of the diagnosis of the fracture was of
64.77  13.78 years old (30–90 years old). The diagnosis in
male patients occurred at an average age of 61.96 years old,
approximately 4 years earlier than in female patients, in
whom the average age at the time of diagnosis was of 66.23
years old. About 70% of the patients (n ¼ 59)were in their 7th
and 8th decades of life when the humeral pathological
fracture was diagnosed. Most of the patients were female
(69.51%; n ¼ 57). Approximately 90% of the fractures were
established, and only 8 impending fractures were treated.
Most of the fractures occurred on the right side (48.84%;
n ¼ 42), and 4 patients had bilateral fractures, 3 of them
simultaneously and 1 at different times, equivalent to 86
surgically treated fractures in 82 patients. The regional
distribution of tumor lesions along the 3 thirds of the
humeral shaft, in decreasing order (►Fig. 3), was the follow-
ing: medial diaphysis (44.19%; n ¼ 38), proximal diaphysis
(36.05%; n ¼ 31), and distal diaphysis (19.77%, n ¼ 17). A
total of 12 patients (14.63%) had a previous history of
pathological fractures in other anatomical sites, 8 in the
Fig. 1 Complete pathological fracture of the medial humeral shaft and nail fixation.
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dorsolumbar spine, and 4 in the femur. Primary tumors were
located predominantly in the following anatomical areas, in
descending order (►Fig. 4): breast (30.49%; n ¼ 25), blood
(26.83%; n ¼ 22), lung (10.98%; n ¼ 9), kidney (8.54%;
n ¼ 7), prostate (4.88%; n ¼ 4), thyroid (3.66%; n ¼ 3), lar-
ynx (2.44%; n ¼ 2) and brain (2.44%; n ¼ 2). Here, multiple
myeloma is considered a primary (hematopoietic) blood
tumor. In two patients, the primary tumor remained unspec-
ified. Tumor diseases that most frequently caused patholog-
ical fractures were metastatic bone disease and multiple
myeloma. The most prevalent primary tumors were breast
carcinoma (30.49%; n ¼ 25), multiple myeloma (24.39%;
n ¼ 20), lung adenocarcinoma (8.54%; n ¼ 7) and renal cells
carcinoma (6.10%; n ¼ 5). The most common primary tumor
in women was breast carcinoma (present in 43.86% of the
female patients), whereas, in men, the most frequent prima-
ry tumor was multiple myeloma (affecting 36% of the male
patients).
Fig. 2 Impending pathological fracture of the medial humeral shaft and nail fixation.
Fig. 3 Regional distribution of humeral shaft tumor lesions.
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In most patients (86.59%), the humerus fracture occurred
with a previously diagnosed underlying neoplasia. However,
in 11 cases, the oncological diagnosiswas onlymade after the
pathological fracture, which was assumed as the 1st cancer
manifestation and motivated an etiological screening. The
mean time between the diagnosis of the primary neoplasm
and the humeral pathological fracture was of 37.58  2.40
months. The mean time of surgical nail fixation was of
90.16  42.98 minutes (40–135 minutes), and the mean
hospitalization time was of 8.23  5.27 days (2–33 days).
Most of the nailing procedures occurred via the antegrade
approach (68.60%; n ¼ 59), while the remainder were per-
formed through the retrograde approach (31.40%; n ¼ 27).
The dimensions of the nails were customized in a case-per-
case basis, considering the anatomical characteristics of the
humerus from each patient. The most frequently used nails
were 6.7 mm (66.28%; n ¼ 57) and 7.5 mm (16.28; n ¼ 14)
in diameter and 250 mm in length (19.77%; n ¼ 17, ranging
from 205 to 360 mm). Three locking screws were most often
used (86.05%; n ¼ 74) and, in the remaining cases, the nail
was locked with a total of 4 screws, with 2 proximal screws
and 2 distal screws.
In clinical-functional terms, all of the patients reported
improvement in arm pain, and the mean MSTS score in-
creased from 26% to 72.6% in the evaluation performed in
individuals still alive 3 months after the surgery. With the
inclusion of only 57 patients with established fractures who
survived for at least 3 months after the procedure, the
radiographic consolidation rate in the operated humeri
was of 77.19%.
The mean survival time after the surgery was of
309.29  33.71 days, and the median time was of
196 days, with the highest number of deaths occurring
during the 1st postoperative year. The survival rate at
90 days (3 months) after surgery was 69.50%, with 56.10%
at 180 days (6 months), 26.70% at 365 days (1 year), and
11.90% at 730 days (2 years). There were no deaths in the
immediate postoperative period, but 5 patients (6.10%) died
during the 1st month after the surgery. Survival analysis of
the sample is shown in ►Fig. 5 with a Kaplan-Meyer curve.
No death was relatedwith the surgery or with complications
associated with it.
There were only 4 surgery-related complications, 1 in the
early intraoperative period and 3 late complications, corre-
sponding to a total complication risk of 4.65%. Complications
included an iatrogenic fracture of the distal humerus in a
retrograde procedure, requiring open reduction and fixation
with plaque, screws and cerclage; a proximal nail migration
due to loss of fixation of the proximal screws due to the
growth of the tumor lesion, requiring the removal of the nails
Fig. 4 Anatomical location of primary tumors. Note: Multiple mye-
loma was considered a primary blood (hematopoietic) tumor.
Fig. 5 Kaplan-Meyer curve showing the accumulated survival rates, in days, of the sample after humeral nailing.
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and of the screws; a pullout of one from two proximal locking
screws, requiring its isolated extraction; and a subacromial
impingement syndrome caused by the nail; these last three
procedures were performed through the antegrade ap-
proach. When extracting the proximally migrating nail, it
was found intraoperatively that the fracture was consolidat-
ed. There were no cases of neurovascular injury, embolism,
infection, heterotopic ossification, refracture or other alter-
ations. There was no significant difference in the MSTS
functional score, postoperative survival time, and occur-
rence of complications according to age, gender, established
or impending fracture and its distribution in the humeral
shaft, primary tumor type, surgical approach, nail dimen-
sions, and the number of locking bolts used.
Discussion
Although life expectancy increased in the last decades, most
patients suffering fromapathologicalhumeral fracture second-
ary to disseminated tumor disease have an estimated short
survival timeof1 year, asdemonstratedby thepresent study,
in which the mean postoperative survival time was of
309.29  33.71 days, with a median time of 196 days. As
such, it is imperative that the chosen treatment focus on
immediate pain control and early function restitution to
minimize associated morbidity and provide a better quality
of life in patients whose general condition is
compromised.1,2,4–6 8–12,20–22 The current gold standard ap-
proach forpathological fracturesof thehumeral shaft isfixation
with proximal and distal static interlocking rigid intramedul-
lary nails.1,3–7,10,13–15As far aswe know, the present study has
the largest sample in terms of humeral diaphyseal fractures
treatment with rigid intramedullary nails in the literature in
the English language. As shown in the present series, whose
results areconfirmedbysimilar studies, static interlocking rigid
nails are a safe and biomechanically effective implant, allowing
a stable fixation against angulation, rotation, distraction and
compression forces to stabilize the humerus in the context of
diaphyseal pathological fractures; moreover, this is a relatively
fast interventionwith a short hospital stay that assuresfixation
of thearmandconsequentlyprovidespaincontroland function
restauration, tolerating immediate limb mobilization and im-
proving thequalityof life. Inaddition, thenail allowsabypass to
the diaphyseal tumor lesion and, as a result, the implant is
stably fixed in the healthy proximal and distal bone, reducing
the risk of fixation failure. It also ensures prophylactic protec-
tion of a long humeral segment against new fractures and,
consequently, further surgery due to eventual disease progres-
sion or new metastasis. Since this is a closed reduction tech-
nique (with no opening of the fracture site), there is reduced
blood loss, fasterhealing, anda lower riskof infection, aswell as
the possibility of adjuvant radiotherapy immediately after
surgerywith no significant riskof impaired healing, decreasing
the risk of tumor progression and, consequently, reducing
symptoms and/or fixation failures that require surgical
revision.1–10,13–17,23,24 Although these patients are frequently
more concerned with pain relief than with limb function, we
consider that the functional improvement obtained from the
mean MSTS score from 26% to 72.6% is quite satisfactory.
Despite the previously mentioned reduced potential for the
consolidation of pathological fractures, the stable fixation
provided by the nail combined with the antineoplastic radio-
therapy and chemotherapy probably allowed the consolidation
indexesobservedinthepresent sample(evaluatedonly inthose
who survived > 3 months after the surgery), which were
deemed very satisfactory (77.19%). These rates were similar
to the ones observed by Pretell et al1 (80%) and by Atesok et al9
(88%),withan incidenceofcomplicationsdue tofixation failure
limited to 1 case.1,2,9,11
Our series had just four complications, andonlyoneof them
was intraoperative, consisting in an iatrogenic humeral frac-
ture during the insertion of the nail; most of the sample
obtained a stable humeral fixation throughout the remaining
life time. Although some studies have reported important
levels of complicationswith thenailing of pathological humer-
al fractures, inparticular nerve lesionsduring theplacementof
locking screws, iatrogenic fractures during nail insertion, and
failure in thefixation of the locking screws,most studies agree
with our findings and also refer to a minimal incidence of
surgical complications.1,2,4–10,13,14,25 The antegrade approach
has beenmore associatedwith shoulder pain and stiffness due
to iatrogenic rotator cuff injury, whereas the retrograde ap-
proach is most associated with iatrogenic humeral fractures
during the insertion of thenails.1,2,10,13Nevertheless, onlyone
of each of these complications was observed during the
present study; we attribute this to the nailing technique
used and to the experience of the surgical team. Moreover,
we believe that most operative complications reported in the
literaturemay not occur if the surgical technique is the correct
one. The reduced rate of shoulder problems due to the ante-
grade nail entry point in our sample could be explained by the
single deltoid and cuff incisions with cold blade and its
adequate closure to protect these structures during nail inser-
tion, as well as the care not to displace the nail. However, we
should also consider that the lower functional expectations
and greater pain tolerance of terminal cancer patients proba-
bly have some impact on the reduced prevalence of shoulder
pain after antegrade humeral nailing procedures.9 We have
also considered that the adequate choice of the nail diameter
was relevant toprevent intraoperative iatrogenic fracturesand
to increase the stability of osteosynthesis. It is important to fill
most of the humeral medullary cavity to decrease the likeli-
hoodoffixation failures by instability. In turn,wealso consider
that the absence of pulmonary embolism in the sample
warrants the use of unreamed nails in cancer patients with
an increasedriskof this complication.2,26Thelimitationsof the
present study include its retrospective nature, the lack of data
from somepatients, and the loss of some individuals at follow-
up due to the reduced life expectancy in metastatic cancer
patients.
Conclusion
The use of unreamed rigid interlocking static intramedul-
lary nail by the antegrade or retrograde approach is a
treatment method that meets the requirements of a patient
Rev Bras Ortop Vol. 54 No. 2/2019



















































with short life expectancy and symptomatic pathological
humeral fracture, since it is a fast, effective, safe, low
morbidity technique that ensures stable and immediate
bone fixation, resulting in pain relief, functional improve-
ment, and increased quality of life.
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